研究单位：[1]Shanghai Jiao Tong University School of Medicine[2]Xinhua hospital affiliated shanghai jiaotong university school of medicine [3]Xuanwu Hospital, Beijing[4]Capital Medical University[5]Peking University First Hospital[6]Tianjin Medical University Cancer Institute and Hospital[7]The First Affiliated Hospital of Dalian Medical University[8]China Medical University, China[9]The first clinical college of harbin medical university[10]The Second Affiliated Hospital of Harbin Medical University[11]Shengjing Hospital[12]Jilin University[13]The people's hospital of Heilongjiang province[14]Eastern Hepatobiliary Surgery Hospital[15]Shanghai Changzheng Hospital[16]Shandong Provincial Hospital[17]Qilu Hospital of Shandong University[18]Air Force Military Medical University, China[19]Tang-Du Hospital[20]Qinghai People's Hospital[21]Affiliated Hospital of Qinghai University[22]First Affiliated Hospital of Chongqing Medical University[23]Daping Hospital and the Research Institute of Surgery of the Third Military Medical University[24]First People's Hospital of Kunming[25]Lanzhou university second hospital[26]Xi'an Central Hospital[27]The first people's hospital of Guiyang[28]Southwest Hospital, China[29]The First Affiliated Hospital of Kunming Medical College
Objective Primary:
Determine the objective response rate in patients with advanced gallbladder treated with new Chemotherapy regimen
Secondary:
Determine time to progression-free survival and overall survival of patients treated with this regimen.
Determine quality of life of patients treated with this regimen. Determine the toxicity of new chemotherapy regimen
